Alcobra Ltd. engages in the research, development, and market of pharmaceutical productsfor the treatment of ... More | Chart | Post
Full Profile of ADHD (Alcobra Ltd.) : Nasdaq
Market Cap: 38.59M | Industry: Health Care/Life Sciences
Alcobra Ltd. engages in the research, development, and market of pharmaceutical productsfor the treatment of central nervous system disorders and cognitive dysfunctions. Its portfolio includes Metadoxine Extended Release to treat Attention Deficit Hyperactivity Disorder...
Alcobra Ltd. engages in the research, development, and market of pharmaceutical productsfor the treatment of central nervous system disorders and cognitive dysfunctions. Its portfolio includes Metadoxine Extended Release to treat Attention Deficit Hyperactivity Disorder...